Feedback / Questions
Memogain (galantamine prodrug) - Alpha Cognition
https://www.businesswire.com/news/home/20231207840612/en/Alpha-Cognition-Announces-FDA-Acceptance-of-New-Drug-Application-for-ALPHA-1062-for-Mild-to-Moderate-Alzheimer%E2%80%99s-Disease
Dec 7, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next